Use of substances having oxytocin antagonistic properties for the preparation of a medicament for treating hypertension
Details for Australian Patent Application No. 2005206159 (hide)
International Classifications
Event Publications
20 July 2006 PCT application entered the National Phase
PCT publication WO2005/070449 Priority application(s): WO2005/070449
1 March 2007 Change of Name(s) of Applicant(s), Section 104
Ferring B.V. The name of the applicant has been changed to Ferring B.V.; Garfield, Robert
22 March 2007 Assignment before Grant
Garfield, Robert Edward The application has been assigned to Ferring B.V.
18 December 2008 Application Accepted
Published as AU-B-2005206159
23 April 2009 Standard Patent Sealed
5 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005206163-Lipid-based dispersions useful for drug delivery
2005206157-Universal interference cleat for vertebral prosthesis
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser